Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
PURPOSE: Fatigue is a distressing symptom occurring in more than 60% of patients with cancer. The CNS stimulants modafinil and methylphenidate are recommended for the treatment of cancer-related fatigue, despite a limited evidence base. We aimed to evaluate the efficacy and tolerability of modafinil...
Main Authors: | Spathis, A, Fife, K, Blackhall, F, Dutton, S, Bahadori, R, Wharton, R, O'Brien, M, Stone, P, Benepal, T, Bates, N, Wee, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Clinical Oncology
2014
|
Similar Items
-
Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial
by: Spathis, A, et al.
Published: (2014) -
A multicenter, randomized, double-blinded, placebo-controlled trial of modafinil for lung cancer-related fatigue: Dose response and patient satisfaction data.
by: Fife, K, et al.
Published: (2013) -
Modafinil for multiple sclerosis fatigue: does it work?
by: Littleton, E, et al.
Published: (2010) -
Effects of Modafinil on Sleep Pattern during Methamphetamine Withdrawal: A Double-blind Randomized Controlled Trial
by: Seyed Mohamad Moosavi, et al.
Published: (2019-07-01) -
Short- and Long-Term Efficacy of Modafinil at Improving Quality of Life in Stroke Survivors: A Post Hoc Sub Study of the Modafinil in Debilitating Fatigue After Stroke Trial
by: Thomas P. Lillicrap, et al.
Published: (2018-04-01)